Sign in

Duke-Margolis Institute for Health Policy

@dukemargolis.bsky.social
465 followers 131 following 222 posts

The Institute's Mission is to improve health, health equity, and the value of health care through practical, innovative, and evidence-based policy solutions.

PostsRepliesMedia
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 3h
A draft agenda is now available for our upcoming webinar! Join us on October 29 to learn more about the home-based serious illness care ecosystem and opportunities to support delivery and sustainable scaling. Check out the agenda and register here: duke.is/z/63f7
Advancing a Home-Based Serious Illness Care Ecosystem: Recent Policy Advancements and Future Directions. October 29, 2026, 1-2pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 25/09/2026
Founding Director Mark McClellan and fellow former FDA Commissioner Scott Gottlieb co-authored an op-ed in STAT on Heidi Overton, current nominee for FDA Commissioner, and her opportunity to bridge the gap between biomedical innovation and the institutions that move progress forward: duke.is/2/mws6
statnews.com
Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Ahead of Heidi Overton’s confirmation hearing for FDA commissioner, two former commissioners review her experience and approach.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 25/09/2026
Our next event is just a few days away! Join us for the next RISE workshop, co-convened with the FDA Rare Disease Innovation Hub, where speakers will explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products: duke.is/2/z3fw
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations. September 29, 2026, 9am - 4:30pm ET. A hybrid public workshop. National Press Club, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 24/09/2026
As Duke-Margolis continues to expand and broaden our impact, we are pleased to share that Kate Bundorf has been appointed Co-Director with Founding Director Mark McClellan. Together, they will strengthen our work to advance health policy research and educate the next generation: duke.is/y/9pmt
The graphic features a photo of Mark McClellan and Kate Bundorf standing together on a bridge in a sunny, forested area. Next to the photo is the Duke-Margolis Institute for Health Policy logo, both set atop on waves of blue and yellow. The accompanying text reads, “McClellan, Bundorf Named Co-Directors of Duke-Margolis Institute.”
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 24/09/2026
In just a few weeks, we are hosting an event in DC with West Health to explore the future of accountable care. While the model has largely proven more effective than traditional fee-for-service payment, next steps are less clear. Join us on October 14: duke.is/b/9kxj
The graphic features a photo of a puzzle shaped like a heart, with a hand holding one missing piece. A stethoscope lies next to the puzzle. The accompanying text reads, “Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions. October 14, 2026, 1-5pm ET. A hybrid public workshop. Ronald Reagan Building, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy. West Health Duke-Margolis Accelerator: Powering reliable, accountable care for a healthier America.”
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 23/09/2026
Join us on October 29 for a new public webinar, where we will explore actionable policy strategies to improve access and strengthen accountability to support the sustainable scaling of a home-based medical care ecosystem for older adults with serious illness: duke.is/z/63f7
Advancing a Home-Based Serious Illness Care Ecosystem: Recent Policy Advancements and Future Directions. October 29, 2026, 1-2pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 18/09/2026
Mark McClellan contributed to this new white paper published by the World Economic Forum, in collaboration with Boston Consulting Group, which explores what it will take to move outcome-based care from isolated pilots to system-wide practice: duke.is/r/pff2
weforum.org
Access Denied
021
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 17/09/2026
Speakers have been announced for our upcoming event, co-convened with the FDA Rare Disease Innovation Hub! Hear from experts on 9/29 as they explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products: duke.is/2/z3fw
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations. Sept 29, 2026, 9am - 4:30 pm ET. A hybrid public workshop. National Press Club, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 15/09/2026
As 2027 approaches, what comes next for accountable care? Join Duke-Margolis and West Health in Washington, DC, on 10/14 for a discussion on how evidence, technology, and innovation can help accelerate accountable care and address persistent challenges. Register: duke.is/b/9kxj
The graphic features a photo of a puzzle shaped like a heart, with a hand holding one missing piece. A stethoscope lies next to the puzzle. The accompanying text reads, “Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions. October 14, 2026, 1-5pm ET. A hybrid public workshop. Ronald Reagan Building, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy. West Health Duke-Margolis Accelerator: Powering reliable, accountable care for a healthier America.”
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 14/09/2026
Check out our latest white paper! In this paper, Duke-Margolis researchers explore opportunities to modernize risk adjustment. Reforms could not only improve predictive accuracy, but also support a more patient-centered health care system. Read more here: duke.is/6/hcng
A Vision for Modernizing Medicare Risk Adjustment: Building the Evidence for Reform. West Health Accelerator at Duke-Margolis; Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 10/09/2026
A draft agenda is now available for our upcoming event! On October 14, we are exploring the future of accountable care and modernizing the infrastructure that supports it. A free networking reception will follow the event—we invite you to join us in-person to connect with your peers: duke.is/b/9kxj
Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions. October 14, 2026, 1-5pm ET. A hybrid public workshop. Ronald Reagan Building, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 09/09/2026
Join us on 9/29 as we convene a hybrid event with the FDA Rare Disease Innovation Hub! Speakers will explore statistical considerations for rare disease investigations. Read the draft agenda and register here: duke.is/2/z3fw
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations. September 29, 2026, 9 am - 4:30 pm ET. A hybrid public workshop. National Press Club, Washingtdon, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 03/09/2026
A new public event has been announced! Join us in DC next month for an event that will explore progress in accountable care to-date and opportunities to leverage evidence that can accelerate accountable care: duke.is/b/9kxj
Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions. October 14, 2026, 1-5pm ET. A hybrid public workshop. Ronald Reagan Building, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 31/08/2026
TOMORROW: Join us for the Innovation in Quantitative Medicine Summit, starting at 12pm ET! We are co-convening this virtual event with the FDA's Quantitative Medicine Center of Excellence to inform the establishment of the Quantitative Medicine Innovation Network. Register here: duke.is/8/4p56
Innovation in Quantitative Medicine Summit. September 1, 2026, 12:00 - 4:30 pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 21/08/2026
Don't miss your chance to register! The FDA is hosting a public workshop, convened by Duke-Margolis under a cooperative agreement with the FDA, to discuss challenges & opportunities to advance the use of digitally-derived endpoints in clinical trials for drug & biological products: duke.is/4/7rtf
The graphic features a photo of a hand wearing a watch overlaid in holographic health-related symbols to represent wearable digital health tools. The surrounding text reads, "Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials. August 27, 2026, 9:30-3:45pm ET. Virtual via Zoom. U.S. Food and Drug Administration; Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 19/08/2026
A draft agenda is now available for our upcoming workshop on statistical considerations for rare disease investigations! Read more about the session topics and register here: duke.is/2/z3fw
A futuristic image of a bar graph is the background of this graphic, with accompanying text: “RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations. September 29, 2026, 9am – 4:30 pm ET. A hybrid public workshop. National Press Club, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.”
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 17/08/2026
The Health Care Payment Learning & Action Network (HCPLAN) has released a new Patient Empowerment Guidebook, which was developed for providers, health plans, employers, and community-based organizations to help make care more affordable, ensure patients can access the services
NEW: The Patient Empowerment Guidebook. HCPLAN (Health Care Payment Learning & Action Network).
100
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 10/08/2026
Evidence suggests that the MMBP pathway has not yet become a practical route for state drug value-based purchasing arrangements. Our new policy brief examines why + identifies potential operational & policy improvements that could make the pathway a more feasible contracting option: duke.is/j/gce3
healthpolicy.duke.edu
Evaluating the Medicaid Multiple Best Prices Provision as a Pathway for Value-Based Purchasing
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 06/08/2026
On 9/1, Duke-Margolis and the FDA's Quantitative Medicine Center of Excellence are co-convening a virtual event to inform the establishment of the Quantitative Medicine Innovation Network. A draft agenda is now available! Learn more about the topics of discussion and register here: duke.is/8/4p56
Innovation in Quantitative Medicine Summit. September 1, 2026, 12-4pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
001
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 05/08/2026
On September 29, Duke-Margolis and the FDA Rare Disease Innovation Hub are co-convening a new hybrid workshop to explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products: duke.is/2/z3fw
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations. September 29, 2026, 9am - 4:30 pm ET. A hybrid public workshop. National Press Club, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 04/08/2026
On August 10, Institute Director Mark McClellan and Core Faculty member David Ridley are speaking at a hybrid symposium hosted by CSIS Renewing American Innovation program and Duke University on the importance of the NC Research Triangle region for biopharmaceutical innovation: duke.is/b/f3zv
csis.org
Spotlighting the North Carolina Research Triangle's Biopharmaceutical Manufacturing and Innovation Hub | CSIS Events
The North Carolina Research Triangle is a world-class innovation hub for biopharmaceuticals, supported by a robust research university system. This innovation ecosystem is a national security asset for U.S. global innovation competitiveness in life sciences.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 30/07/2026
A draft agenda is available for the upcoming virtual workshop, "Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials," which we are convening under a cooperative agreement with the U.S. Food and Drug Administration. Learn more and register here: duke.is/4/7rtf
Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials. August 27, 2026, 9:30 am - 3:45 pm ET. U.S. Food and Drug Administration; Duke-Margolis Institute for Health Policy. Virtual via Zoom.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 29/07/2026
Margolis Scholar alum Sydney Grube (MBA '26) spoke about her Bass Connections project, "Advancing Community-Based Models of Health and Social Care in North Carolina," in a profile published on the program website. Read more here: duke.is/m/4h39
bassconnections.duke.edu
Sydney Grube (Master of Business Administration ’26) | Bass Connections
“[Participating in Bass Connections] gave me a lot of practice approaching people with openness, transparency and curiosity and managing a project while staying flexible
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 21/07/2026
On August 27, the FDA is hosting a public workshop, convened by the Duke-Margolis Institute for Health Policy under a cooperative agreement with the FDA, to discuss statistical considerations for digitally-derived endpoints in clinical trials for drug and biological products: duke.is/4/7rtf
Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials. August 27, 2026, 9:30 am - 3:45 pm ET. U.S. Food and Drug Administration; Duke-Margolis Institute for Health Policy. Virtual via Zoom.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 17/07/2026
Join us on 7/27 for our annual State of RWE Policy convening, where experts will consider how RWD/E can routinely inform regulatory and coverage decisions, integrate research into patient care, and foster greater harmonization across the health policy ecosystem: duke.is/2/ynaf
2026 State of Real-World Evidence Policy. July 27, 2026, 12-4:45pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 15/07/2026
Drop by the Duke Summer Research Showcase on Friday, July 24, from 10:00 am - 12:00 pm at Bostock Library, The Edge, to support over 130 student researchers—including our wonderful Summer Experience interns—who are presenting posters about their Duke-sponsored summer research. #DukeExperiences
Duke Summer Research Showcase. Friday, July 24, 10am-12pm. Bostock Library, The Edge. Participating programs: Duke Undergraduate Research Support Office, Duke-Margolis Institute for Health Policy, PRIME Cancer, Duke Pratt School of Engineering, Athena AI Institute, Duke Department of Psychology and Neuroscience, Duke Experiential Education, Amgen Scholars Program, and D-Care.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 10/07/2026
Join us next week for our hybrid workshop as we examine opportunities to improve how biomarker evidence supports regulatory decision-making in individual product submissions. Learn more about our speakers & topics of discussion, read our preliminary policy roadmap, and register here: duke.is/2/7sb2
Advancing Biomarker Use in Regulatory Review: Evidence, Engagement, and Ecosystem Opportunities. July 15, 2026, 10:00 am - 4:30 pm ET. A hybrid public workshop. Convene, WAshington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 01/07/2026
Duke-Margolis has created a new framework of Real-World Evidence (RWE) Policy Core Competencies, a skillset that will prepare tomorrow’s RWE policy leaders to solve today’s—and tomorrow’s—toughest RWE policy challenges with evidence, innovation, and impact. Read more here: duke.is/4/scwe
Real-World Evidence Policy Core Competencies for Today and Tomorrow’s Learners. Policy Development, Evaluation, Translation & Communication. Data & Methods. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 30/06/2026
Join us for a new virtual workshop on September 1! Duke-Margolis & the FDA's Quantitative Medicine Center of Excellence are co-convening this event to inform the establishment of the Quantitative Medicine Innovation Network, which aims to transform drug development & clinical care: duke.is/8/4p56
Innovation in Quantitative Medicine Summit. September 1, 2026, 12 -4 pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 23/06/2026
Influenza is a persistent public health challenge with significant morbidity, mortality, and economic costs. Duke-Margolis has released a new policy brief that outlines short- and long-term policy priorities to modernize seasonal influenza vaccine development: duke.is/2/4va5
Modernizing Influenza Vaccine Development: Policy Priorities for Stakeholders. Duke-Margolis Institute for Health Policy.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 18/06/2026
Don't miss your chance to register! Our next event is coming up on Tuesday, June 23, where we will explore opportunities to modernize seasonal influenza vaccine development. Register today: duke.is/m/smgn
Policy Priorities to Modernize Seasonal Influenza Vaccine Development. June 23, 1-2pm. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 12/06/2026
Join us for our annual State of Real-World Evidence Policy convening on 7/27! Speakers will consider how RWD/E can routinely inform regulatory and coverage decisions, integrate research into patient care, and foster greater harmonization across the health policy ecosystem: duke.is/2/ynaf
2026 State of Real-World Evidence Policy. July 27, 2026, 12 - 4:45 pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 09/06/2026
Join us on July 15 for a hybrid workshop designed to inform a policy roadmap to improve the use of biomarkers and surrogate endpoints in regulatory decision-making for individual product submissions. Learn more and register here: duke.is/2/7sb2
Advancing Biomarker Use in Regulatory Review: Evidence, Engagement, and Ecosystem Opportunities. July 15, 2026, 10am - 5pm ET. A hybrid public workshop. Downtown Washington, DC, Venue TBC, or virtual via Zoom. Duke-Margolis Instittue for Health Policy.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 04/06/2026
Our next event is just a few weeks away! Join us on June 23 for a webinar where we will explore policy actions to facilitate a more efficient development of seasonal influenza vaccines. For more details on this discussion, check out the new draft agenda: duke.is/m/smgn
Policy Priorities to Modernize Seasonal Influenza Vaccine Development. June 23, 1-2pm. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 27/05/2026
Missed out on the 2026 Health Policy Conference or want to review the discussion that took place? An event summary is now available to read and share! The summary provides quick highlights from each session and features some quotes from our speakers: duke.is/HPC2026Summary
Driving Health Policy Transformation in the Next Decade. Duke-Margolis Institute 2026 Health Policy Conference. Wednesday, May 12, 2026, 12:30 - 5:15 pm. Westin Hotel Downtown DC.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 21/05/2026
Influenza is a persistent public health challenge with significant morbidity, mortality, and economic costs. Join us on 6/23 for a webinar focused on prioritized policy actions to help realize innovative viral surveillance and development: duke.is/m/smgn
Policy Priorities to Modernize Seasonal Influenza Vaccine Development. June 23, 2026, 1-2pm ET. Virtual via Zoom. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 20/05/2026
We would like to sincerely thank the Peterson Center on Healthcare for their support of our 2026 Health Policy Conference. The Center was established by the Peter G. Peterson Foundation to make higher-quality, more affordable health care a reality for all Americans: petersonhealthcare.org
Peterson Center on Healthcare logo
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 18/05/2026
Our 2026 Health Policy Conference featured a group of wonderful speakers and timely health policy topics, but the conversation was only possible through the support of our sponsors. We offer our most sincere thanks to Johnson & Johnson for sponsoring this year’s conference: www.jnj.com
Johnson & Johnson logo
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 15/05/2026
We extend our most sincere thanks to Alexandria Ventures for sponsoring our 2026 Health Policy Conference. Their support will allow us to continue gathering annually and host these crucial health policy conversations. Learn more about Alexandria here: www.are.com
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 11/05/2026
Our annual conference is just a few days away! Join us this Wednesday, May 13, for an afternoon packed with timely health policy discussions as we celebrate 10 years of Duke-Margolis. Register today: duke.is/HPC2026
Driving Health Policy Transformation in the Next Decade. Duke-Margolis Institute 2026 Health Policy Conference. Wednesday, May 13, 2026. 12:30 - 5:15 pm. Westin Hotel Downtown DC.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 08/05/2026
We’re excited to discuss many timely health policy topics at the 2026 Health Policy Conference! This event is only made possible through our sponsors, so we would like to thank the Peterson Center on Healthcare for their support. The Center was established by the Peter G.
Peterson Center on Healthcare logo
100
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 07/05/2026
The Duke-Margolis ReVAMP Drug Supply Consortium has released a new Framework to Address Chronic Drug Shortages, which outlines six priority areas where the federal government can respond to chronic drug shortages that create higher mortality rates, medication errors, delays in
100
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 05/05/2026
We would like to thank Johnson & Johnson for their generous support of our upcoming conference! J&J has been tackling the world’s toughest health challenges for 140 years, aiming to keep people well at every age and every stage of life: www.jnj.com/our-company
100
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 01/05/2026
A draft agenda is now available for our upcoming meeting! Join us on May 19 as we explore solutions to chronic drug shortages, national health security risks associated with foreign dependence, and challenges related to quality assurance: duke.is/v/4g5n
ReVAMPing the Pharmaceutical Supply Chain: Creating a Reliable Domestic Supply. A hybrid public meeting. Duke in DC Office, Washington, DC, or virtual via Zoom. Duke-Margolis Institute for Health Policy. May 19, 2026, 1-4pm ET.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 30/04/2026
Our 2026 Health Policy Conference is just around the corner! We would like to thank Alexandria Ventures for sponsoring this event that creates an important space for health policy discussion.
Alexandria Venture Investments logo
110
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 27/04/2026
WEDNESDAY: Join Duke-Margolis and the U.S. Food and Drug Administration (FDA) for a public webinar to provide updates on RCT-DUPLICATE, one of the FDA’s demonstration projects addressing key methodological challenges in studies using real-world data. Register today: duke.is/4/5a35
U.S. Food and Drug Administration Webinar on the RCT-DUPLICATE Initiative: Emulating Randomized Clinical Trials with Non-Randomized Real-World Data Studies. April 29, 2026, 12-1pm ET. Virtual via Zoom. U.S. Food and Drug Administration; Duke-Margolis Institute for Health Policy.
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 23/04/2026
Congratulations to Research Director Rachele Hendricks-Sturrup for being inducted into the inaugural class of Fellows of the Association for Clinical and Translational Science (ACTS)! Read more here: duke.is/2/qksh
medschool.duke.edu
Four Duke leaders named as inaugural Fellows of ACTS
The Association for Clinical and Translational Science (ACTS) fellows program recognizes individuals who have made substantial contributions to and service within the clinical and translational science field and who are an essential part of the clinical and translational community. 
010
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 22/04/2026
You won't want to miss this upcoming event! On May 19, we are hosting a hybrid meeting to discuss strategies to strengthen domestic drug supply chain reliability. Join us as we explore solutions to chronic drug shortages: duke.is/v/4g5n
ReVAMPing the Pharmaceutical Supply Chain: Creating a Reliable Domestic Supply. A hybrid public workshop. Duke in DC Office, WAshington, DC, or virtual via zoom. May 19, 2026, 1-4:30 pm ET. Duke-Margolis Institute for Health Policy.
000
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 21/04/2026
This Thursday: Join Duke-Margolis and the U.S. Food and Drug Administration for a conversation on "Increasing Access to Nonprescription Drugs"! Register today: duke.is/p/4g3b
Increasing Access to Nonprescription Drugs. April 23, 2026, 12:30 - 5:00 pm ET. National Press Club, Washington, DC, or virtual via Zoom. A hybrid public meeting. Duke-Margolis Institute for Health Policy.
020
Duke-Margolis Institute for Health Policy @dukemargolis.bsky.social · 16/04/2026
Join Duke-Margolis and the FDA on April 29 for a free webinar on RCT-DUPLICATE, a demonstration project on using real-world data to generate valid evidence. Learn how studies can emulate trials and support regulatory decisions. Register today: duke.is/4/5a35
U.S. Food and Drug Administration Webinar on the RCT-DUPLICATE Initiative. April 29, 2026, 12-1pm ET. Virtual via Zoom. FDA U.S. Food and Drug Administration; Duke-Margolis Institute for Health Policy.
000